No concern about IGF-1-related side effects (joint pain, acromegaly risk at extreme doses)
In some embodiments, auris formulations or compositions described herein are controlled release formulations, and are administered at reduced dosing frequency compared to the current standard of care
Causes & What to Know Many patients taking GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), or liraglutide (Victoza, Saxenda) report changes in urination patterns
The medications, also known as GLP-1s, have surged in popularity for weight loss but were initially developed to treat diabetes
Most users notice improvements in skin clarity and tone within 4 to 6 weeks of consistent use
Trizepitides unique mechanism of action enhances its effectiveness in weight management, which is particularly relevant for our local population facing obesity